Company
Headquarters: New Taipei City, Taiwan
Employees: 163
CEO: Mr. P. H. Huang
TW$3.29 Billion
TWD as of Jan. 1, 2025
US$100.2 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures and sells pharmaceutical materials and products in Taiwan. The company offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamin, anti-inflammatory, cough and cold, pain reliever, etc. It provides its products in the solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. The company was incorporated in 1966 and is based in New Taipei City, Taiwan.
Johnson Chemical Pharmaceutical Works Co. Ltd has the following listings and related stock indices.
Stock: TWSE: 4747 wb_incandescent